Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
Mary MathiasAby AbrahamMark J BelletruttiManuel CarcaoManuela CarvalhoHervé ChambostAnthony K C ChanLeonid DubeyJonathan M DucoreMichael GattensPaolo GreseleYves GruelPhilippe GautierVictor Jimenez YusteLidija KitanovskiAnna KlukowskaSunil LohadeMaria Elisa MancusoJohannes OldenburgBerardino PollioMarianne SigaudKateryna VilchevskaJohn K M WuMartina JansenLarisa BelyanskayaOlaf WalterSigurd KnaubEllis J NeufeldPublished in: European journal of haematology (2023)
Simoctocog alfa was efficacious and well tolerated as prophylaxis, surgical prophylaxis and for the treatment of BEs in PUPs with severe haemophilia A.